Medical Device News Magazine

Study Confirms Pelvic Floor Patients Overwhelmingly Prefer “In-person” to “Virtual-only” for at Home Care

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Luna, the leading provider of in-home physical therapy, has unveiled a new patient study, which casts doubt on virtual-only care for pelvic floor disorders.

In the study, 97% of patients with pelvic floor disorders preferred to receive in-person physical therapy at home, with only 3% favoring app-based care, and the majority of patients agreed that they “would not even seriously consider a virtual-only care option.”

The study revealed that 71% of patients receiving Luna’s in-home physical therapy for pelvic floor disorders showed statistically significant functional improvement with only 7 in-person visits needed on average.

Hinge Health recently launched a program for female pelvic floor disorders soon after its competitor SWORD Health announced its own pelvic health program. Luna provides effective pelvic floor care for all genders, in the familiarity, security, and privacy of their homes.

“The study demonstrates that in-person physical therapy, as opposed to virtual-only, is the go-to treatment for pelvic floor disorders. This means that companies, including Hinge Health and SWORD Health, are missing a huge opportunity for patient care,” said Palak Shah, Luna co-founder and head of clinical operations.

“Luna’s in-home physical therapy, accessible nationwide, provides effective pelvic floor care from the comfort and safety of their homes, while avoiding the hassles of going to a clinic, at no extra cost as treatment is covered by insurance,” added Shah.

To request in-home physical therapy care for pelvic floor disorders, patients can call or visit getluna.com, and no referral is needed to start treatment. Once requested, the physical therapist will arrive at the patient’s home equipped to treat the patient.

Luna is the nation’s fastest growing provider of on-demand, in-home physical therapy, with more than 4,000 therapists in 2022, treating a wide range of conditions. It operates in 42 U.S. markets and 24 states, and partners with some of the most innovative health systems nationally, including Emory Health, SCL Health, UCLA Health, and Scripps Health.

33% of women will experience a pelvic floor disorder in her lifetime, while 16% of men have been identified with a pelvic floor disorder, and is a growing concern as the world’s population ages. Pelvic floor disorders occur with weakened pelvic muscles or tears in the connective tissue, which may impact everyday physiological functions, such as controlling bowel and bladder continence and sexual function.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”